TAS1R3 and Insulin resistance: Furthermore, we demonstrated that both direct pharmacological inhibition and the siRNA knockdown of TAS1R3 contributes to decreased insulin-stimulated glucose uptake in human LHCN-M2 myotubes, consistent with the impaired glucose tolerance and insulin resistance phenotype observed in the TAS1R3 knockout mice [33].